Simone Seyringer

Innsbruck, 6020, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.

Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.

Journal: PharmacoEconomics

Published: April 08, 2025

Erratum to "Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence" [Eur J Cancer (2025) 115235].

Erratum to "Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence" [Eur J Cancer (2025) 115235].

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 02, 2025

Critical issues with methods and results interpretation at validating the EQ-5D-5L and QLU-C10D utilities in gastric cancer patients : Referring to: Pan, C. W., he, J. Y., Zhu, Y. B., Zhao, C. H., Luo, N., & Wang, P.: Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. The European journal of health economics, 24(6), 885-893 (2003).

Critical issues with methods and results interpretation at validating the EQ-5D-5L and QLU-C10D utilities in gastric cancer patients : Referring to: Pan, C. W., he, J. Y., Zhu, Y. B., Zhao, C. H., Luo, N., & Wang, P.: Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. The European journal of health economics, 24(6), 885-893 (2003).

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: December 03, 2024

Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence.

Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 15, 2024

The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.

The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: October 30, 2024

Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.

Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.

Journal: PharmacoEconomics - open

Published: March 11, 2024

Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.

Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.

Journal: Scientific reports

Published: February 27, 2024

Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.

Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: February 14, 2024

Bottom Up Ethics - Neuroenhancement in Education and Employment.

Bottom Up Ethics - Neuroenhancement in Education and Employment.

Journal: Neuroethics

Published: February 08, 2018

Public views on gene editing and its uses.

Public views on gene editing and its uses.

Journal: Nature biotechnology

Published: November 10, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026